85 related articles for article (PubMed ID: 11020263)
1. Simple 1,2-aminoalcohols as strain-specific antimalarial agents.
Howarth J; Lloyd DG
J Antimicrob Chemother; 2000 Oct; 46(4):625-8. PubMed ID: 11020263
[TBL] [Abstract][Full Text] [Related]
2. Analysis of antimalarial synergy between bestatin and endoprotease inhibitors using statistical response-surface modelling.
Gavigan CS; Machado SG; Dalton JP; Bell A
Antimicrob Agents Chemother; 2001 Nov; 45(11):3175-81. PubMed ID: 11600374
[TBL] [Abstract][Full Text] [Related]
3. Optimization of plasmepsin inhibitor by focusing on similar structural feature with chloroquine to avoid drug-resistant mechanism of Plasmodium falciparum.
Miura T; Hidaka K; Azai Y; Kashimoto K; Kawasaki Y; Chen SE; de Freitas RF; Freire E; Kiso Y
Bioorg Med Chem Lett; 2014 Apr; 24(7):1698-701. PubMed ID: 24631188
[TBL] [Abstract][Full Text] [Related]
4. Synthesis, antimalarial evaluation and molecular modeling studies of hydroxyethylpiperazines, potential aspartyl protease inhibitors, part 2.
Cunico W; Gomes CR; Facchinetti V; Moreth M; Penido C; Henriques MG; Varotti FP; Krettli LG; Krettli AU; da Silva FS; Caffarena ER; de Magalhães CS
Eur J Med Chem; 2009 Sep; 44(9):3816-20. PubMed ID: 19403210
[TBL] [Abstract][Full Text] [Related]
5. Synthesis and evaluation of new antimalarial phenylurenyl chalcone derivatives.
Domínguez JN; León C; Rodrigues J; Gamboa de Domínguez N; Gut J; Rosenthal PJ
J Med Chem; 2005 May; 48(10):3654-8. PubMed ID: 15887974
[TBL] [Abstract][Full Text] [Related]
6. Antiplasmodial activities of 4-aminoquinoline-statine compounds.
Vaiana N; Marzahn M; Parapini S; Liu P; Dell'Agli M; Pancotti A; Sangiovanni E; Basilico N; Bosisio E; Dunn BM; Taramelli D; Romeo S
Bioorg Med Chem Lett; 2012 Sep; 22(18):5915-8. PubMed ID: 22884991
[TBL] [Abstract][Full Text] [Related]
7. Synthesis and in vitro evaluation of new chloroquine-chalcone hybrids against chloroquine-resistant strain of Plasmodium falciparum.
Sashidhara KV; Avula SR; Palnati GR; Singh SV; Srivastava K; Puri SK; Saxena JK
Bioorg Med Chem Lett; 2012 Sep; 22(17):5455-9. PubMed ID: 22850213
[TBL] [Abstract][Full Text] [Related]
8. Synthesis of aminoquinoline-based aminoalcohols and oxazolidinones and their antiplasmodial activity.
Kobarfard F; Yardley V; Little S; Daryaee F; Chibale K
Chem Biol Drug Des; 2012 Mar; 79(3):326-31. PubMed ID: 22129095
[TBL] [Abstract][Full Text] [Related]
9. Exploring the flap pocket of the antimalarial target plasmepsin II: the "55 % rule" applied to enzymes.
Zürcher M; Gottschalk T; Meyer S; Bur D; Diederich F
ChemMedChem; 2008 Feb; 3(2):237-40. PubMed ID: 17918177
[No Abstract] [Full Text] [Related]
10. Docking, synthesis and antimalarial activity of novel 4-anilinoquinoline derivatives.
Vijayaraghavan S; Mahajan S
Bioorg Med Chem Lett; 2017 Apr; 27(8):1693-1697. PubMed ID: 28318947
[TBL] [Abstract][Full Text] [Related]
11. Synthesis and antimalarial activity of thioetherhydroxyethylsulfonamides, potential aspartyl protease inhibitors, Part 3.
Vellasco Junior WT; Guedes GP; Vasconcelos TR; Vaz MG; de Souza MV; Krettli AU; Krettli LG; Aguiar AC; Gomes CR; Cunico W
Eur J Med Chem; 2011 Nov; 46(11):5688-93. PubMed ID: 21982338
[TBL] [Abstract][Full Text] [Related]
12. KBE009: An antimalarial bestatin-like inhibitor of the Plasmodium falciparum M1 aminopeptidase discovered in an Ugi multicomponent reaction-derived peptidomimetic library.
González-Bacerio J; Maluf SEC; Méndez Y; Pascual I; Florent I; Melo PMS; Budu A; Ferreira JC; Moreno E; Carmona AK; Rivera DG; Alonso Del Rivero M; Gazarini ML
Bioorg Med Chem; 2017 Sep; 25(17):4628-4636. PubMed ID: 28728898
[TBL] [Abstract][Full Text] [Related]
13. Screening of protease inhibitors as antiplasmodial agents. Part I: Aziridines and epoxides.
Schulz F; Gelhaus C; Degel B; Vicik R; Heppner S; Breuning A; Leippe M; Gut J; Rosenthal PJ; Schirmeister T
ChemMedChem; 2007 Aug; 2(8):1214-24. PubMed ID: 17562535
[TBL] [Abstract][Full Text] [Related]
14. Identification of phosphinate dipeptide analog inhibitors directed against the Plasmodium falciparum M17 leucine aminopeptidase as lead antimalarial compounds.
Skinner-Adams TS; Lowther J; Teuscher F; Stack CM; Grembecka J; Mucha A; Kafarski P; Trenholme KR; Dalton JP; Gardiner DL
J Med Chem; 2007 Nov; 50(24):6024-31. PubMed ID: 17960925
[TBL] [Abstract][Full Text] [Related]
15. Plasmodium chabaudi chabaudi and P. falciparum: inhibition of aminopeptidase and parasite growth by bestatin and nitrobestatin.
Nankya-Kitaka MF; Curley GP; Gavigan CS; Bell A; Dalton JP
Parasitol Res; 1998 Jul; 84(7):552-8. PubMed ID: 9694371
[TBL] [Abstract][Full Text] [Related]
16. Stage-specific antimalarial activity of cysteine protease inhibitors.
Shenai BR; Semenov AV; Rosenthal PJ
Biol Chem; 2002 May; 383(5):843-7. PubMed ID: 12108550
[TBL] [Abstract][Full Text] [Related]
17. Antimalarial benzo[c]phenanthridines.
Nyangulu JM; Hargreaves SL; Sharples SL; Mackay SP; Waigh RD; Duval O; Mberu EK; Watkins WM
Bioorg Med Chem Lett; 2005 Apr; 15(8):2007-10. PubMed ID: 15808457
[TBL] [Abstract][Full Text] [Related]
18. Antimalarial activity enhancement in hydroxymethylcarbonyl (HMC) isostere-based dipeptidomimetics targeting malarial aspartic protease plasmepsin.
Hidaka K; Kimura T; Ruben AJ; Uemura T; Kamiya M; Kiso A; Okamoto T; Tsuchiya Y; Hayashi Y; Freire E; Kiso Y
Bioorg Med Chem; 2008 Dec; 16(23):10049-60. PubMed ID: 18952439
[TBL] [Abstract][Full Text] [Related]
19. A new class of phenazines with activity against a chloroquine resistant Plasmodium falciparum strain and antimicrobial activity.
Hussain H; Specht S; Sarite SR; Saeftel M; Hoerauf A; Schulz B; Krohn K
J Med Chem; 2011 Jul; 54(13):4913-7. PubMed ID: 21591758
[TBL] [Abstract][Full Text] [Related]
20. Design, synthesis and in vitro antiplasmodial activity of some bisquinolines against chloroquine-resistant strain.
Kondaparla S; Agarwal P; Srivastava K; Puri SK; Katti SB
Chem Biol Drug Des; 2017 Jun; 89(6):901-906. PubMed ID: 27896925
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
